SCILEX PHARMACEUTICALS, INC.

SCILEX PHARMACEUTICALS INC. specializes in the manufacturing of pharmaceutical preparations, with demonstrated experience producing drugs, hematological agents, and related therapeutic products for federal healthcare systems. The company’s core capabilities center on compliant, quality-assured production of finished dosage forms, adhering to current Good Manufacturing Practices (cGMP) and regulatory standards for pharmaceutical supply chains. Their technical expertise includes formulation development, batch processing, packaging, and quality control systems tailored to meet the stringent requirements of government procurement. While specific product lines are not disclosed, their work under the Federal Supply Schedule suggests a focus on high-demand, clinically essential medications used in Veterans Health Administration settings. The Department of Veterans Affairs is the sole agency reflected in their award history, indicating a targeted relationship focused on supplying pharmaceuticals through the FSS program. This suggests alignment with VA’s priorities for reliable, secure, and cost-effective access to critical medications for veteran populations, likely supporting outpatient, inpatient, and specialty care needs. The primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), which encompasses the formulation, synthesis, and packaging of active pharmaceutical ingredients into final dosage forms such as tablets, capsules, injectables, and oral solutions. The company positions itself within the federal pharmaceutical supply market as a specialized manufacturer serving mission-critical healthcare delivery systems. SCILEX PHARMACEUTICALS INC. operates as a private entity with no disclosed certifications or geographic presence. Their government market positioning is narrow but focused, centered on direct pharmaceutical supply to federal healthcare providers through established procurement channels. The absence of certifications suggests a reliance on operational compliance and product quality rather than formal socio-economic designations.